CapsoVision, Inc

CapsoVision, Inc. develops and commercializes capsule endoscopy solutions for gastrointestinal diagnosis, centered on its CapsoCam line of ingestible imaging capsules. The company combines disposable capsule hardware with software and cloud-based viewing workflows, including CapsoView and CapsoCloud, to help clinicians capture and review GI-tract videos. Its revenue comes from product sales, reading services, and software-as-a-service delivery options, with sales tied primarily to the number of capsules sold. CapsoVision is still in an investment phase, funding product development, regulatory work, and commercial expansion while continuing to report operating losses.

−186,7 %

52,9 %

−186,8 %

+15,3 %

3.77

3.09

— CapsoVision, Inc
%
Capsule endoscopy hardware65% Ingestible imaging capsules sold for GI-tract diagnostic procedures.
Cloud and software delivery20% CapsoCloud and CapsoView tools used to upload, access, and review capsule videos.
Reading and interpretation services15% Physician or service-center review of capsule videos and generation of reports.

CapsoVision sells primarily to medical practices, clinics, hospitals, and physician groups that use capsule endoscopy...

  • Hospitals and health systemsprimary

    Buy CapsoCam capsules and associated viewing workflows to diagnose GI-tract conditions in clinical settings.

  • Medical practices and clinicsprimary

    Purchase capsule devices and reading services for outpatient GI diagnostics and patient throughput.

  • Physician groups and readerssecondary

    Use the video interpretation service and software tools to review capsule footage and produce reports.

  • GPO-affiliated healthcare memberssecondary

    Buy through group purchasing organizations that negotiate procurement for member practices and hospitals.

  • Government and defense-related healthcare facilitiesemerging

    Adopt CapsoCloud and capsule workflows when the company can meet stricter IT security requirements.

CapsoVision is a U.S.-based company, but its operating footprint is international because its cloud offering must...

  • •United States is the core commercial and reporting base
  • •Asia, especially Taiwan and Japan, is central to component sourcing and assembly
  • •International CapsoCloud deployments require country-specific privacy and security compliance
  • •U.S. government-related customers require additional IT security controls
  • •Tariffs and trade policy changes can affect imported component costs
  • •Shipping reliability matters because capsules and components must move quickly and securely

CapsoVision is focused on expanding adoption of its GI-tract capsule endoscopy platform across new indications, patient...

01
Regulatory expansion for new productsshort-term

Commercial growth depends on securing clearances for CapsoCam Colon and AI-enabled capsules.

02
Commercial scale-upmedium-term

The business needs broader physician and hospital adoption to increase capsule volumes and service usage.

03
Supply chain resilienceshort-term

Single-source and Asia-based suppliers create concentration risk that can disrupt product availability.

04
Funding the businessshort-term

Ongoing losses and cash burn require access to external financing to support operations and growth.

CapsoVision faces the classic risks of an early commercial medtech company: regulatory dependence, reimbursement...

high

Regulatory clearance delays

New products such as CapsoCam Colon and AI-enabled capsules need 510(k) clearance before broad commercialization.

Scope
Product launch timing and market access
Materiality
high
high

Supply chain concentration

Critical components and assembly are concentrated with suppliers in Taiwan and Japan, many of them single-source.

Scope
Manufacturing continuity and gross margin
Materiality
high
high

Reimbursement uncertainty

Adoption depends on Medicare and other payors approving adequate reimbursement for the GI-tract solution.

Scope
Commercial adoption and pricing
Materiality
high
high

Liquidity and going-concern risk

The company continues to incur losses and expects to need additional funding to support operations.

Scope
Financing, dilution, and execution
Materiality
high
medium

Data privacy and cybersecurity compliance

CapsoCloud must meet country-specific privacy rules and enhanced security requirements for some government customers.

Scope
International expansion and customer retention
Materiality
medium
Revenue recognition mix
Can shift revenue between periods depending on shipment and service delivery timing
GPO deductions
Reduces reported revenue and can obscure underlying gross demand
Stock-based compensation
Impacts reported losses and dilution analysis
Inventory and supply chain costs
Affects cost of revenue, margins, and working capital
Lease commitments
Relevant to near-term cash needs and fixed-cost structure

CAPSTONE COMPANIES, INC.

CAPC · Electric Lighting & Wiring Equipment

COOPER COMPANIES, INC.

COO · Ophthalmic Goods

BIOMERICA INC

BMRA · In Vitro & In Vivo Diagnostic Substances

VASO Corp

VASO · Electromedical & Electrotherapeutic Apparatus

Odysight.ai Inc.

ODYS · Services-Computer Integrated Systems Design

ESCALON MEDICAL CORP

ESMC · Electromedical & Electrotherapeutic Apparatus

: 28/04/2026